FdaApplication
ANDA 216037
Identifiers
- fda_app_no: ANDA216037
Properties
| Property | Value |
|---|---|
| applicant_name | MEITHEAL PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2023-12-26 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| THIOTEPA | THIOTEPA | 15MG/VIAL | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL |
| THIOTEPA | THIOTEPA | 100MG/VIAL | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL |
2 products